| Aug 28 |
Biotech Stock Roundup: REGN's Drug Approval, LXRX, RYTM Stocks Gain on Update & More
|
| Aug 27 |
High Growth Tech Stocks To Watch In August 2024
|
| Aug 26 |
FDA sets target action date for Rhythm's sNDA for Imcivree
|
| Aug 26 |
Rhythm Pharmaceuticals Announces FDA Acceptance for Priority Review of Supplemental New Drug Application for IMCIVREE® (setmelanotide) in Patients as Young as 2 years old
|
| Aug 26 |
Rhythm Pharmaceuticals to Present at Wells Fargo Healthcare Conference in September
|
| Aug 9 |
Analysts Are Updating Their Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Estimates After Its Second-Quarter Results
|
| Aug 6 |
Rhythm Pharmaceuticals, Inc. 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 6 |
Rhythm Pharmaceuticals, Inc. (RYTM) Q2 2024 Earnings Call Transcript
|
| Aug 6 |
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 6 |
Rhythm Pharmaceuticals GAAP EPS of -$0.55 beats by $0.15, revenue of $29.08M beats by $0.29M
|
